IFNA1 and Dravet syndrome: One key conclusion from these efforts is that the interferonopathy of DS should be considered as a “mixed-type interferonopathy” associated with widespread overexpression of type I, type II, and type III IFNRs, with clear potential for type II and type III IFNs to be major contributors to IFN hyperactivity and dysregulation of downstream events.